Home › GSK, Pfizer must lower price of vital vaccine: Medecins sans Frontieres
 

Keywords :   


GSK, Pfizer must lower price of vital vaccine: Medecins sans Frontieres

2015-01-25 03:07:53| Biotech - Topix.net

Two giant pharmaceutical companies should lower the price of a new vaccine against pneumococcal disease that is needed by children in developing countries, but is unaffordable for some of their governments, say the volunteer doctors of Medecins sans Frontieres . In a report on vaccine pricing, MSF says British company GlaxoSmithKline and US giant Pfizer should slash the price of the vaccines to US$5 per child in developing countries.

Tags: price lower sans vital

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.06Post Office accidentally leaks sub-postmaster data
20.06Farm Progress America, June 20, 2024
20.06Farm Progress America, June 20, 2024
20.06Tropical Storm Alberto Graphics
20.06Tropical Storm Alberto Forecast Discussion Number 11
20.06Tropical Storm Alberto Forecast Advisory Number 11
20.06Summary for Tropical Storm Alberto (AT1/AL012024)
20.06NatWest to buy Sainsbury's banking arm
More »